ViewsML
viewsml.com
Actively hiring
Medical Imaging Systems
Medical AI
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$4.9M
1 round on record
Latest round
$4.9M
Seed · Apr 2026 · 5 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Apr 2026 | $4.9M | — | debiopharm.com |
Similar startupsby what they do, their industry and backers
Discover Diagnocat, the leading dental AI software for accurate diagnostics. Enhance your practice with AI-powered dental diagnosis…
Shukun Technology builds medical imaging artificial intelligence for cardiovascular, neurological and oncology diagnosis in Chinese…
Quibim is a Valencian medical imaging company founded in 2012 and specialised in quantitative image biomarkers. Its algorithms extract…
Vara is a Berlin company founded in 2018 that builds artificial intelligence for breast cancer screening. Its software reads mammograms to…
Cystotech ApS is a Danish MedTech company developing a medical software support tool based on artificial intelligence to help detect and…
AZmed builds artificial intelligence that detects fractures and lesions on radiographs. Its Rayvolve software supports emergency radiology…
Overview
Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
News
ViewsML Raises $4.9M for AI-Driven Virtual Biomarker Staining Platform
ViewsML secures a $4.9M seed round backed to replace physical pathology lab staining with AI-driven virtual biomarkers.
Read more
Report
ViewsML secures $4.9 million to help scientists virtually analyze tissue samples
Wittington, Mayo Clinic back startup's plan to build world's first virtual biomarker library. The post ViewsML secures $4.9 million to help scientists virtually analyze tissue samples first appeared on BetaKit.
Read more
Report
ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform
VANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscrib
Read more
Report
Viewsml And Iprocess Announce Strategic Partnership To Accelerate Delivery Of AI-Powered Virtual Biomarker Testing
Viewsml And Iprocess Announce Strategic Partnership To Accelerate Delivery Of AI-Powered Virtual Biomarker Testing.ViewsML TechnologiesiProcess Global ResearchPartnership brings ViewsML
Read more
Report
ViewsML and Debiopharm Collaborate to Advance Virtual Biomarker Technology in Drug Research
Debiopharm taps ViewsML's AI-driven platform to streamline biomarker detection in oncology research.
Read more
Report
Pro access
Upgrade to see all 7 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Financials
Total raised
$4.9M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2026 | $4.9M | Details |